← Leaderboards
D Craig Brater
Indiana Univ-Purdue Univ At Indianapolis
$2,021,339
Attributed
$2,021,339
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2005–08$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
Funding mix
By agency
NIH$27,419,261 · 7
By mechanism
M01$25,398,919 · 5
R01$1,649,653 · 1
T32$370,689 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- John Howard Pratt$5,209,827
- Dale D. Tang$10,552,712
- Alexander G. Obukhov$4,800,135
- Victor P Fomin$100,000
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectFurosemideCongestive Heart FailureDiureticsHuman Therapy EvaluationClinical Trial Phase IHeart Disorder ChemotherapyPharmacokineticsDrug Screening /EvaluationAlpha Antiadrenergic AgentAdenosineKidney Disorder ChemotherapyChronic Renal FailureSulfonamidesCardiovascular Disorder ChemotherapyDrug InteractionsRenal Tubular TransportSodiumSpironolactoneAcetazolamideChlorothiazideLongitudinal Human StudyLiver Disorder Chemotherapy
Grant awards (41)
General Clinical Research Center$549,938
M01 · FY2008 · RR · contact PI
General Clinical Research Center$3,139,712
M01 · FY2007 · RR · contact PI
General Clinical Research Center$3,139,304
M01 · FY2006 · RR · contact PI
General Clinical Research Center$3,137,842
M01 · FY2005 · RR
GENERAL CLINICAL RESEARCH CENTER$3,123,079
M01 · FY2004 · RR
CLINICAL PHARMACOLOGY OF LOOP DIURETICS$339,081
R01 · FY2004 · AG
Diuretics on Response to Torsemide in Patients with Congestive Heart Failure$997
M01 · FY2004 · RR
GENERAL CLINICAL RESEARCH CENTER$2,994,851
M01 · FY2003 · RR
CLINICAL PHARMACOLOGY OF LOOP DIURETICS$339,851
R01 · FY2003 · AG
General Clinical Research Ctr:Pharmacogenetics Core Supp$88,702
M01 · FY2003 · RR
GENERAL CLINICAL RESEARCH CENTER$3,136,486
M01 · FY2002 · RR
CLINICAL PHARMACOLOGY OF LOOP DIURETICS$340,594
R01 · FY2002 · AG
CLINICAL PHARMACOLOGY TRAINING GRANT$98,475
T32 · FY2002 · GM
ALBUMIN INFUSION ON RESPOSE TO FUROSEMIDE IN CIRRHOSIS$0
M01 · FY2002 · RR
CHLORZOXAZONE IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2002 · RR
BG9719 &FUROSEMIDE FOR CONGESTIVE HEART FAILURE &RENAL INSUFFICIENCY$0
M01 · FY2002 · RR
GENERAL CLINICAL RESEARCH CENTER$3,312,631
M01 · FY2001 · RR
CLINICAL PHARMACOLOGY OF LOOP DIURETICS$347,413
R01 · FY2001 · AG
CLINICAL PHARMACOLOGY TRAINING GRANT$139,794
T32 · FY2001 · GM
BG9719 &FUROSEMIDE FOR CONGESTIVE HEART FAILURE &RENAL INSUFFICIENCY$0
M01 · FY2001 · RR
CHLORZOXAZONE IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2001 · RR
ALBUMIN INFUSION ON RESPOSE TO FUROSEMIDE IN CIRRHOSIS$0
M01 · FY2001 · RR
GENERAL CLINICAL RESEARCH CENTER$2,725,458
M01 · FY2000 · RR
CLINICAL PHARMACOLOGY OF LOOP DIURETICS$282,714
R01 · FY2000 · AG
CLINICAL PHARMACOLOGY TRAINING GRANT$132,420
T32 · FY2000 · GM
GCRC-CAP-HELMUT STEINBERG, M.D. (ADDITIONAL TIME)$49,919
M01 · FY2000 · RR
ALBUMIN INFUSION ON RESPOSE TO FUROSEMIDE IN CIRRHOSIS$0
M01 · FY2000 · RR
ALBUMIN INFUSION ON RESPOSE TO FUROSEMIDE IN CIRRHOSIS$0
M01 · FY2000 · RR
CHLORZOXAZONE IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2000 · RR
CHLORZOXAZONE IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2000 · RR
CHLORZOXAZONE IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2000 · RR
CHLORZOXAZONE IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2000 · RR
CHLORZOXAZONE IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2000 · RR
BG9719 &FUROSEMIDE FOR CONGESTIVE HEART FAILURE &RENAL INSUFFICIENCY$0
M01 · FY2000 · RR
BG9719 &FUROSEMIDE FOR CONGESTIVE HEART FAILURE &RENAL INSUFFICIENCY$0
M01 · FY2000 · RR
BG9719 &FUROSEMIDE FOR CONGESTIVE HEART FAILURE &RENAL INSUFFICIENCY$0
M01 · FY2000 · RR
BG9719 &FUROSEMIDE FOR CONGESTIVE HEART FAILURE &RENAL INSUFFICIENCY$0
M01 · FY2000 · RR
BG9719 &FUROSEMIDE FOR CONGESTIVE HEART FAILURE &RENAL INSUFFICIENCY$0
M01 · FY2000 · RR
ALBUMIN INFUSION ON RESPOSE TO FUROSEMIDE IN CIRRHOSIS$0
M01 · FY2000 · RR
ALBUMIN INFUSION ON RESPOSE TO FUROSEMIDE IN CIRRHOSIS$0
M01 · FY2000 · RR
ALBUMIN INFUSION ON RESPOSE TO FUROSEMIDE IN CIRRHOSIS$0
M01 · FY2000 · RR